LIAISON® Bone & Mineral Diagnostic Solution
The testing solutions for the detection of 1 - 84 PTH, N-TACT® PTH.
Statement of calcium and phosphorus metabolisms are necessary for the diagnosis of CKD, hyperparathyroidism and hypoparathyroidism, or other calcium metabolism disorders.
Our fully automated bone and mineral chemiluminescencent (CLIA) testing portfolio provides a clinical picture of the patient with CKD, hyperparathyroidism and hypoparathyroidism, or other calcium metabolism disorders.
The LIAISON® testing solutions (1 - 84 PTH, N-TACT® PTH) can aid in assessing the calcium and phosphorus metabolic status.
LIAISON® 1 - 84 PTH
A quantitative 3rd gen. assay for the determination of 1 - 84 PTH without cross reaction to 7-84 and other PTH fragments for use in the assessment of calcium and phosphorus metabolic disorders.
LIAISON® N-TACT® PTH
A quantitative 2nd gen. assay for the determination of the human PTH for use in assessment of calcium and phosphorus metabolic disorders.
Indications for use
Diagnosis
Quantitative assays for the management of bone and calcium metabolism related diseases
Target patient
Adults
Use area
Endocrinology, nephrology, gynecology, geriatric medicine and Internal medicine
Background
Comprehensive menu for the management of
bone and mineral related disorders
LIAISON® Bone & Mineral Diagnostic Solution include valuable tools for the assessment of bone turnover and primary/secondary hyperparathyroidism. Diasorin offers a specialty line of bone and mineral assays providing accuracy and reliability in the management of bone and mineral related diseases.
How it works
The 1-84 PTH assay is used for the quantitative determination of 1-84 PTH, whereas N-TACT® PTH measures 1-84 + 7-84 PTH and other inactive fragments.
1-84 PTH has 0% cross-reactivity to 7-84 and other fragments and is 100% specific to 1-84 PTH. Both assays are useful markers for PTH testing
A fully automated PTH proposal (1-84 & N-TACT® II) for assessment of calcium metabolic disorders
Hypercalcemia
Diagnosis and differential diagnosis of hypercalcemia.
Hyperparathyroidism
Diagnosis of primary and secondary hyperparathyroidism.
Renal osteodystrophy
Monitoring of end stage renal failure patient for possible renal osteodystrophy.
Why use LIAISON® Bone & Mineral Diagnostic Solution
A fully automated 1 - 84 PTH assay with no cross-reactivity with inactive 7-84 PTH fragments
The LIAISON® 1 - 84 PTH assay is an innovative 3rd Generation test highly specific for the active PTH molecule, removing the uncertainty and variability that physicians face when measuring PTH with an intact assay.
A fully automated N-TACT® PTH assay of intact human parathyroid hormone
The LIAISON® N-TACT® PTH assay is a 2nd generation test for the detection of the intact human parathyroid hormone in differential diagnosis of hypercalcemia and hypocalcemia resulting from disorders of calcium metabolism.
To be used on
Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patient and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
LIAISON® XL
Designed for large laboratories. Combine the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
LIAISON® XS
A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.